Hjem › Sklerodermi › Kansas › Kansas City
Sklerodermi kliniske forsøg i Kansas City, KS
4 studier for Sklerodermi søger deltagere på steder i og omkring Kansas City (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- University of Kansas Cancer Center, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
- University of Kansas Medical Center, Kansas City
Sklerodermi forsøg i andre byer
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Chicago, IL10 studier
- Houston, TX9 studier
- Boston, MA7 studier
- Durham, NC7 studier
- Los Angeles, CA7 studier
- New Orleans, LA6 studier
- Philadelphia, PA6 studier
- Baltimore, MD6 studier
- Dallas, TX5 studier
- Pittsburgh, PA5 studier
Andre studier i Kansas City
- Kardiovaskulær sygdom14 studier
- Interstitielle lungesygdomme13 studier
- Hjertesvigt13 studier
- Overvægt13 studier
- Cystisk fibrose13 studier
- Blærecancer12 studier
- Prostatakræft12 studier
- Brystkræft12 studier
- Ikke-småcellet lungecancer11 studier
- Akut myeloid leukæmi11 studier
- Lungecancer11 studier
- KOL9 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.